Nodality's Single Cell Network Profiling (SCNP) provides functional pathway analysis of signaling networks that regulate important cellular functions such as growth, proliferation, and survival. This proprietary platform uses multiparametric flow cytometry that measures, simultaneously and quantitatively, both extracellular surface markers and changes in intracellular signaling proteins in response to biologically relevant modulators at the single cell level.

Nodality's SCNP has the potential to improve the productivity and efficiency of drug development by providing insight to disease biology and effects of pharmacologic agents. Nodality can facilitate competitive advantages in drug development by accelerating, optimizing, and de-risking clinical trials. In addition, Nodality's development of companion diagnostics can best match individual patients with the most appropriate treatments.

Nodality takes Top Honors as “Most Promising Company” at PMWC 2011.